1-6 of 6
genetic risk
Close
Sort by
Journal Articles

Measurable residual disease in elderly acute myeloid leukemia: results from the PETHEMA-FLUGAZA phase 3 clinical trial

Clinical Trials & Observations
Catia Simoes, Bruno Paiva, David Martínez-Cuadrón, Juan-Miguel Bergua, Susana Vives, Lorenzo Algarra, Mar Tormo, Pilar Martinez, Josefina Serrano, Pilar Herrera, Fernando Ramos, Olga Salamero, Esperanza Lavilla, Cristina Gil, Jose-Luis Lopez, Maria-Belen Vidriales, Jorge Labrador, Jose-Francisco Falantes, María-José Sayas, Rosa Ayala, Joaquin Martinez-Lopez, Sara Villar, Maria-Jose Calasanz, Felipe Prosper, Jesús F. San-Miguel, Miguel Ángel Sanz, Pau Montesinos
Journal: Blood Advances
Blood Adv (2021) 5 (3): 760–770.
https://doi.org/10.1182/bloodadvances.2020003195
Published: 2021
Includes: Supplemental data
Journal Articles

Evaluating upfront high-dose consolidation after R-CHOP for follicular lymphoma by clinical and genetic risk models

Clinical Trials & Observations
Stefan Alig, Vindi Jurinovic, Mohammad Shahrokh Esfahani, Sarah Haebe, Verena Passerini, Johannes C. Hellmuth, Erik Gaitzsch, William Keay, Natyra Tahiri, Anna Zoellner, Andreas Rosenwald, Wolfram Klapper, Harald Stein, Alfred Feller, German Ott, Annette M. Staiger, Heike Horn, Martin L. Hansmann, Christiane Pott, Michael Unterhalt, Christian Schmidt, Martin Dreyling, Ash A. Alizadeh, Wolfgang Hiddemann, Eva Hoster, Oliver Weigert
Journal: Blood Advances
Blood Adv (2020) 4 (18): 4451–4462.
https://doi.org/10.1182/bloodadvances.2020002546
Published: 2020
Includes: Supplemental data
Journal Articles

Prognostic impact of the ELN2017 risk classification in patients with AML receiving allogeneic transplantation

Juliane Grimm, Madlen Jentzsch, Marius Bill, Karoline Goldmann, Julia Schulz, Dietger Niederwieser, Uwe Platzbecker, Sebastian Schwind
Journal: Blood Advances
Blood Adv (2020) 4 (16): 3864–3874.
https://doi.org/10.1182/bloodadvances.2020001904
Published: 2020
Includes: Supplemental data
Journal Articles

Integrating clinical features with genetic factors enhances survival prediction for adults with acute myeloid leukemia

Clinical Trials & Observations
Douglas R. A. Silveira, Lynn Quek, Itamar S. Santos, Anna Corby, Juan L. Coelho-Silva, Diego A. Pereira-Martins, Grant Vallance, Benjamin Brown, Luciana Nardinelli, Wellington F. Silva, Elvira D. R. P. Velloso, Antonio R. Lucena-Araujo, Fabiola Traina, Andy Peniket, Paresh Vyas, Eduardo M. Rego, Israel Bendit, Vanderson Rocha
Journal: Blood Advances
Blood Adv (2020) 4 (10): 2339–2350.
https://doi.org/10.1182/bloodadvances.2019001419
Published: 2020
Includes: Supplemental data
Journal Articles

Clinical, laboratory, and genetic risk factors for thrombosis in sickle cell disease

Andrew Srisuwananukorn, Rasha Raslan, Xu Zhang, Binal N. Shah, Jin Han, Michel Gowhari, Robert E. Molokie, Victor R. Gordeuk, Santosh L. Saraf
Journal: Blood Advances
Blood Adv (2020) 4 (9): 1978–1986.
https://doi.org/10.1182/bloodadvances.2019001384
Published: 2020
Includes: Supplemental data
Journal Articles

Validation of the United Kingdom copy-number alteration classifier in 3239 children with B-cell precursor ALL

Clinical Trials & Observations
Lina Hamadeh, Amir Enshaei, Claire Schwab, Cristina N. Alonso, Andishe Attarbaschi, Gisela Barbany, Monique L. den Boer, Judith M. Boer, Marcin Braun, Luciano Dalla Pozza, Sarah Elitzur, Mariana Emerenciano, Larisa Fechina, Maria Sara Felice, Eva Fronkova, Irén Haltrich, Mats M. Heyman, Keizo Horibe, Toshihiko Imamura, Marta Jeison, Gábor Kovács, Roland P. Kuiper, Wojciech Mlynarski, Karin Nebral, Ingegerd Ivanov Öfverholm, Agata Pastorczak, Rob Pieters, Henriett Piko, Maria S. Pombo-de-Oliveira, Patricia Rubio, Sabine Strehl, Jan Stary, Rosemary Sutton, Jan Trka, Grigory Tsaur, Nicola Venn, Ajay Vora, Mio Yano, Christine J. Harrison, Anthony V. Moorman
Journal: Blood Advances
Blood Adv (2019) 3 (2): 148–157.
https://doi.org/10.1182/bloodadvances.2018025718
Published: 2019
Includes: Supplemental data